Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

glycosides

glycosides is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 5
Pipeline programs 1
News articles 0
Drug details — glycosides
Class
—
Route
—
Patents
5
Programs
1
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

glycosides is an FDA-listed pharmaceutical active ingredient.

Key facts

INN glycosides

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. Glycosides Of Tripterygium Wilfordii Hook(GTW) Phase 2 · First People's Hospital · Henoch-Schönlein Purpura Nephritis

Related patents

Browse patents

  1. US 10543283

    Intranasal administration of guanidinylated aminoglycosides

    Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 10472385

    Triterpene-glycosides as sweeteners or sweetener enhancers

    Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 9757468

    Intranasal administration of guanidinylated aminoglycosides

    Expires Mon Sep 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8987216

    Polysulfated glycosides and salts thereof

    Expires Mon Mar 19 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7368102

    Pulmonary delivery of aminoglycosides

    Expires Mon May 01 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is glycosides?

glycosides is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.